• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
12,356 results

United Therapeutics Corporation, Petitioner v. Liquidia Technologies, Inc.

Docket 23-1298, Supreme Court of the United States (June 12, 2024)
Petitioner United Therapeutics Corporation
Respondent Liquidia Technologies, Inc.
cite Cite Docket
Analyze

United Therapeutics Corporation v. Liquidia Technologies, Inc.

Docket 24-1658, U.S. Court of Appeals, Federal Circuit (Apr. 5, 2024)
Patent - Abbreviated New Drug Application (ANDA)
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
Plaintiff - Appellant UNITED THERAPEUTICS CORPORATION
Defendant - Appellee LIQUIDIA TECHNOLOGIES, INC.
cite Cite Docket
Analyze

United Therapeutics Corporation v. Liquidia Technologies, Inc.

Docket 23-1805, U.S. Court of Appeals, Federal Circuit (Apr. 26, 2023)
Appellant UNITED THERAPEUTICS CORPORATION
Appellee LIQUIDIA TECHNOLOGIES, INC.
United Therapeutics Corporation
...
cite Cite Docket
Analyze

United Therapeutics Corporation v. Liquidia Technologies, Inc.

Docket 22-2217, U.S. Court of Appeals, Federal Circuit (Sept. 16, 2022)
Patent - Abbreviated New Drug Application (ANDA)
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
Plaintiff - Cross-Appellant UNITED THERAPEUTICS CORPORATION
Defendant - Appellant LIQUIDIA TECHNOLOGIES, INC.
cite Cite Docket
Analyze

United Therapeutics Corporation v. Liquidia Technologies, Inc.

Docket 22-2133, U.S. Court of Appeals, Federal Circuit (Aug. 18, 2022)
Appellant UNITED THERAPEUTICS CORPORATION
Appellee LIQUIDIA TECHNOLOGIES, INC.
Intervenor KATHERINE K. VIDAL, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office
cite Cite Docket
Analyze

K-fee System GmbH v. Nespresso USA, Inc.

Docket 22-2042, U.S. Court of Appeals, Federal Circuit (July 19, 2022)
Patent
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff - Appellant K-FEE SYSTEM GMBH
Defendant - Appellee NESPRESSO USA, INC.
Defendant SOCIETE DES PRODUITS NESTLE S.A.
...
cite Cite Docket
Analyze

Sanofi-Aventis Deutschland GmbH, Petitioner v. Mylan Pharmaceuticals Inc.

Docket 19-1451, Supreme Court of the United States (July 2, 2020)

cite Cite Docket
Analyze

LIQUIDIA TECHNOLOGIES, INC. v. UNITED STATES FOOD AND DRUG ADMINIST...

Docket 1:24-cv-02428, District Of Columbia District Court (Aug. 21, 2024)
Judge Timothy J. Kelly, presiding
Administrative Procedure Act
DivisionWashington, DC
FlagsTYPE-E
Cause05:0706 Judicial Review of Agency Actions
Case Type899 Administrative Procedure Act
Tags899 Administrative Procedure Act, 899 Administrative Procedure Act
DeadlineThus, according to FDA, it cannot finally approve Yutrepia until that exclusivity expires on May 23, 2025.
Plaintiff LIQUIDIA TECHNOLOGIES, INC.
Defendant UNITED STATES FOOD AND DRUG ADMINISTRATION
Defendant ROBERT M. CALIFF, M.D.
...
cite Cite Docket
Analyze
1 2 3 4 5 ... >>